Interpreting N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in chronic kidney disease (CKD) is challenging due to reduced renal clearance and
Purpose: This study aims to evaluate the ability of radiomic features obtained from technetium-99m dimercaptosuccinic acid (Tc-99m DMSA) planar images to distinguish renal cortical uptake patterns among patients with chronic kidney disease (CKD). We also assessed the association between selected radiomic features and progressive renal function loss during follow-up. Methods: The study included a total of 185 patients: patients with Diabetes mellitus (DM) + hypertension (HTN) diagnosis (Group 1, n = 30), patients with HTN diagnosis alone (Group 2, n = 86), and patients with no history of DM or HTN who were followed for CKD (Group 3, n = 69). Intergroup comparisons were performed using the Kruskal–Wallis test with Bonferroni-corrected post hoc pairwise testing; the proportion of significantly different features was assessed using FDR correction. As a secondary exploratory analysis, the relationship between selected radiomic features and time to first observed ≥20% eGFR decline at follow-up was evaluated using univariate L2-penalised Cox proportional hazards regression with feature selection guided by the events-per-variable principle and model discrimination quantified using Harrell’s C-index. Results: Intensity Kurtosis values showed a statistically significant difference among the groups: −0.11 (−0.31 to 0.12) for Group 1, −0.24 (−0.41 to −0.04) for Group 2, and −0.33 (−0.45 to −0.16) for Group 3 (p = 0.001). Mean Intensity values were found to be 60.66 (31.01–89.39) in Group 1 and 90.46 (72.87–106.34) in Group 3 (p < 0.001). Age, gender, and baseline eGFR did not differ between groups. Radiomic analysis revealed significant intergroup differences predominantly in intensity- and texture-based features, while morphological features showed more limited differentiation. In the secondary exploratory longitudinal analysis, Centre of Mass Shift was the only morphological feature significantly associated with time to first observed ≥20% eGFR decline at follow-up (HR per SD: 0.74; 95% CI: 0.58–0.94; p = 0.015; C-index: 0.57). Conclusions: Radiomic features from Tc-99m DMSA planar images reveal quantitative differences between clinically defined CKD subgroups even when cortical uptake appears visually indistinguishable. The threshold-specific association of Centre of Mass Shift with subsequent eGFR decline, beyond baseline renal function, suggests that DMSA radiomics may provide exploratory prognostic information that warrants prospective validation.
Methicillin-resistant Staphylococcus aureus (MRSA) causes invasive infections that are difficult to treat and associated with high mortality rates due to antibiotic resistance. Frequent hospital admissions, antibiotic use, invasive catheters, and hemodialysis are significant risk factors for MRSA infections. Here, we report a case of a hemodialysis patient with pneumonia and bacteremia caused by MRSA. The patient presented with tenderness at the catheter insertion site, elevated acute-phase reactants in laboratory tests, and lung consolidations. Removal of the infected catheter and administration of appropriate antibiotic therapy resulted in complete resolution of the patient's clinical symptoms and laboratory abnormalities. This case highlights the importance of recognizing that catheter-related bacteremia in hemodialysis patients can lead to metastatic infections and necessitates careful screening.
Background/Objectives: Elevated Procalcitonin (PCT) levels are frequently encountered in clinical practice but may occur in both infectious and non-infectious conditions, making their interpretation challenging. This study evaluated the diagnostic performance of PCT, CRP, and lactate for differentiating sepsis, infectious conditions, and non-infectious conditions in patients with elevated baseline PCT levels. Methods: In this single-center retrospective observational study, 1072 adults presenting to the ED between June and December 2024 with serum PCT ≥ 0.51 ng/mL were included. Patients were classified into sepsis (n = 272), infection (n = 618), and non-infection (n = 182) groups according to the Sepsis-3 criteria and comprehensive clinical adjudication. ROC analyses and DeLong tests were performed to evaluate biomarker performance. Results: For identifying sepsis, PCT demonstrated better discriminatory performance (AUC 0.683) than CRP (AUC 0.619) and lactate (AUC 0.620), with significant differences between PCT and both CRP (p = 0.009) and lactate (p = 0.018). The optimal PCT cut-off was 2.35 ng/mL (sensitivity 65.8%, specificity 59.5%). For differentiating infectious from non-infectious conditions, CRP showed modest discrimination (AUC 0.640), whereas PCT (AUC 0.581) and lactate (AUC 0.439) performed poorly. Lactate showed the highest prognostic performance for in-hospital mortality (AUC 0.598), although overall prognostic accuracy remained limited. Conclusions: In ED patients with elevated baseline PCT levels, PCT showed better discrimination for sepsis than CRP and lactate, whereas CRP performed modestly in differentiating infectious from non-infectious conditions. None of the biomarkers demonstrated sufficient accuracy for standalone clinical use, supporting their role as complementary tools alongside comprehensive clinical assessment and the Sepsis-3 criteria.
6 October 2026 in Clinical and Experimental Nephrology